1. Home
  2. TISI vs MNOV Comparison

TISI vs MNOV Comparison

Compare TISI & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Team Inc.

TISI

Team Inc.

HOLD

Current Price

$15.46

Market Cap

66.9M

ML Signal

HOLD

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.54

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TISI
MNOV
Founded
1973
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.9M
76.5M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
TISI
MNOV
Price
$15.46
$1.54
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
14.2K
103.8K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$884,953,000.00
$257,917.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.73
N/A
52 Week Low
$11.12
$1.13
52 Week High
$24.25
$2.24

Technical Indicators

Market Signals
Indicator
TISI
MNOV
Relative Strength Index (RSI) 47.76 56.81
Support Level $14.58 $1.50
Resistance Level $16.19 $1.60
Average True Range (ATR) 0.82 0.06
MACD 0.07 -0.00
Stochastic Oscillator 44.88 68.42

Price Performance

Historical Comparison
TISI
MNOV

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.

Share on Social Networks: